| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/06/2008 | EP1951199A2 Pharmaceutical or cosmetic composition and a mixed solubilisation method for the production thereof |
| 08/06/2008 | EP1951189A1 Cosmetic and pharmaceutical compositions comprising lauroyl proline and an ester of anhydrohexitol and of an aliphatic carboxylic acid |
| 08/06/2008 | EP1951186A2 Methods for the treatment of hyperhidrosis |
| 08/06/2008 | EP1951060A1 A concentrate derived from a milk product enriched in naturally occurring sialyllactose and a process for preparation thereof |
| 08/06/2008 | EP1951053A2 Cetp inhibitors |
| 08/06/2008 | EP1951051A2 Spirohydantoin tricyclic cgrp receptor antagonists |
| 08/06/2008 | EP1951050A2 Therapeutic compositions and methods |
| 08/06/2008 | EP1951048A2 Flavanols and b-type procyanidins and inflammation |
| 08/06/2008 | EP1951046A2 Methods to enhance chemotherapy |
| 08/06/2008 | EP1951043A2 Chemical compounds |
| 08/06/2008 | EP1951042A2 Spirolactam tricyclic cgrp receptor antagonists |
| 08/06/2008 | EP1951041A2 Chemical compounds |
| 08/06/2008 | EP1874291B1 Use of zinc gluconate for treating hydradenitis suppurativa |
| 08/06/2008 | EP1850670A4 Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof |
| 08/06/2008 | EP1811839A4 Methods and compositions related to esculentoside a |
| 08/06/2008 | EP1773768A4 Pyrrole derivatives as pharmaceutical agents |
| 08/06/2008 | EP1737467A4 Method and composition for treatment of skin conditions |
| 08/06/2008 | EP1725217B1 Processes for the preparation of solid dosage forms of amorphous valganciclovir hydrochloride |
| 08/06/2008 | EP1673371B1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 08/06/2008 | EP1660491B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 08/06/2008 | EP1651621B1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| 08/06/2008 | EP1648882B1 3-fluoro-piperidines as nmda/nr2b antagonists |
| 08/06/2008 | EP1641455B1 Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors |
| 08/06/2008 | EP1638943B1 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 08/06/2008 | EP1635802B1 Method for inhibiting the growth of antibiotic-resistant bacteria by using pentane-1,5-diol |
| 08/06/2008 | EP1592388A4 Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin |
| 08/06/2008 | EP1569596B1 A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| 08/06/2008 | EP1536783B1 Solid formulations comprising an indolinone compound |
| 08/06/2008 | EP1485088B1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 08/06/2008 | EP1476149B1 Substituted hydrazones as inhibitors of cyclooxygenase-2 |
| 08/06/2008 | EP1474144B1 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor |
| 08/06/2008 | EP1474135B9 Indole, azaindole and related heterocyclic pyrrolidine derivatives |
| 08/06/2008 | EP1467710B1 Pharmaceutical composition comprising an oil/water/oil double microemulsion incorporated into a solid support |
| 08/06/2008 | EP1449920B1 Trangenic mice used as model for human pathologies originating from stem cells |
| 08/06/2008 | EP1432714B1 Chemical compounds |
| 08/06/2008 | EP1423383B1 Pyridine substituted furan derivatives as raf kinase inhibitors |
| 08/06/2008 | EP1404641B1 Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same |
| 08/06/2008 | EP1397382B1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 08/06/2008 | EP1397341B1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 08/06/2008 | EP1385523B1 Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment |
| 08/06/2008 | EP1385518B1 Benzimidazolone compounds |
| 08/06/2008 | EP1385515B1 Spiropyrazole compounds |
| 08/06/2008 | EP1377277B1 Pharmaceutical compositions comprising pravastatin for reducing ldl cholesterol levels |
| 08/06/2008 | EP1363875B1 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 08/06/2008 | EP1328515B1 Indoline derivatives and their use as 5-ht2 receptor ligands |
| 08/06/2008 | EP1311475B1 Aminocyclohexane derivatives |
| 08/06/2008 | EP1301460B1 Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry |
| 08/06/2008 | EP1267819B1 Quinoxaline derivatives, compositions containing them und use as UV-filter |
| 08/06/2008 | EP1257298B1 Cosmid dna constructs and methods of making and using the same |
| 08/06/2008 | EP1173757B1 Diagnosis of human kidney diseases |
| 08/06/2008 | EP1133284B2 A process for the preparation of crystalline particles |
| 08/06/2008 | EP1127168B1 Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis |
| 08/06/2008 | EP1015884B1 Methods of identifying molecules that home to angiogenic vasculature in tumors |
| 08/06/2008 | EP1005274B1 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes |
| 08/06/2008 | EP0783474B1 Compounds for the suppression of hiv tat transactivation |
| 08/06/2008 | CN101238370A Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin |
| 08/06/2008 | CN101238137A Derivatives of 4-or 5-aminosalicylic acid |
| 08/06/2008 | CN101238135A Oxazolidinone-quinolone hybrids as antibacterial compounds |
| 08/06/2008 | CN101238134A Process for the preparation of sulfonic acid salts of oxabispidines |
| 08/06/2008 | CN101238133A Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 08/06/2008 | CN101238132A Spirochromanone derivatives as acetyl coenzyme A carboxylase(ACC) inhibitors |
| 08/06/2008 | CN101238131A Bridged piperazine and piperidine derivatives as CCR1 antagonists |
| 08/06/2008 | CN101238128A Azabicyclic heterocycles as cannabinoid receptor modulators |
| 08/06/2008 | CN101238127A Pyrimidine or triazine fused bicyclic metalloprotease inhibitors |
| 08/06/2008 | CN101238126A Pyrrolobenzodiazepines and heteroaryl, aryl and cycloalkylamino ketone derivatives as follicle stimulating hormone receptor -(FSH-R) antagonists |
| 08/06/2008 | CN101238125A Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 08/06/2008 | CN101238124A Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 08/06/2008 | CN101238123A Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehyftogenase type I |
| 08/06/2008 | CN101238121A Fused bicycloheterocycle substituted quinuclidine derivatives |
| 08/06/2008 | CN101238118A Salts and polymorphs of a VEGF-R inhibitor |
| 08/06/2008 | CN101238117A Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 08/06/2008 | CN101238116A Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors |
| 08/06/2008 | CN101238112A Crystalline forms of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-(4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments |
| 08/06/2008 | CN101238111A Cyclic ketal beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 08/06/2008 | CN101238110A Heterocyclic compounds as agonists for the thyroid receptor |
| 08/06/2008 | CN101238109A Indane derivatives as modulator of ion channels |
| 08/06/2008 | CN101238107A Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| 08/06/2008 | CN101238106A Fluoro substituted 2-oxo azepan derivatives |
| 08/06/2008 | CN101238105A Aripiprazole salts |
| 08/06/2008 | CN101238104A Salt ó¾ |
| 08/06/2008 | CN101238103A New saltó± |
| 08/06/2008 | CN101238102A New salt ó |
| 08/06/2008 | CN101238101A 2-(1H-indolylsulfanyl)-aryl amine derivatives |
| 08/06/2008 | CN101238099A Salts of vildagliptin |
| 08/06/2008 | CN101237889A Estrogen compositions for vaginal administration |
| 08/06/2008 | CN101237886A Compositions for affecting weight loss |
| 08/06/2008 | CN101237885A Agent for regeneration and/or protection of nerves |
| 08/06/2008 | CN101237884A Int6 protein involved in hypoxia stress induction and use thereof |
| 08/06/2008 | CN101237878A Intralesional treatment of psoriasis |
| 08/06/2008 | CN101237874A A carbohydrate fraction and use thereof for a flat postprandial glucose response |
| 08/06/2008 | CN101237873A Staurosporine derivatives for treating non-small cell lung cancer |
| 08/06/2008 | CN101237872A Use of tiotropium salts in the treatment of severe persistant asthma |
| 08/06/2008 | CN101237871A Methods and compositions for the treatment of ocular disorders |
| 08/06/2008 | CN101237870A Concomitant pharmaceutical agents and use thereof |
| 08/06/2008 | CN101237869A Pyridone derivatives for modulating stress-activated protein kinase system |
| 08/06/2008 | CN101237868A Nanoparticulate clopidogrel and aspirin combination formulations |
| 08/06/2008 | CN101237867A Novel 4-amino-thieno[3,2-C]pyridine-7-carboxylic acid amides |
| 08/06/2008 | CN101237866A Use of thiazole derivatives and analogues in the treatment of cancer |
| 08/06/2008 | CN101237865A Methods of treatment utilizing certain melatonin derivatives |
| 08/06/2008 | CN101237864A Methods and compositions for soothing oral and nasal tissues |